PHT-1
PT
Menu
Search

Sections

  • Home
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Sectors
    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Disease
      • Oncology
      • Respiratory
  • Themes
    • Artificial Intelligence
    • Corporate Governance
    • Cloud
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19
  • Insights
    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media
  • Companies
    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content
  • Pricing and Market Access
  • Events
  • Reports
  • Premium Insights
  • Excellence Awards
  • Magazine

GlobalData

  • About us
  • Advertise With Us
  • Contact Us
  • Our Marketing Solutions
  • GlobalData Reports
  • Visit GlobalData

From Our Partners

  • Transforming MedTech and Pharma using Software as a Medical Device (SaMD)
  • Accelerating Biopharmaceutical Innovation
  • Accelerating Clinical Trials
  • Precision medicine and digital health innovation for disease diagnosis, care and treatment
  • Enabling process intensification in biopharma manufacturing
  • Specialty drug launch strategy and operations
  • The next chapter of clinical trial services
  • Future Pharma Services
  • Putting quality first in the pharma supply chain
  • Enabling better biopharmaceutical manufacturing
  • Pharmaceutical Grade Silicone Manufacturer
  • Maximising molecule potential
  • News
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Latest

    • Illegal online pharmacies gain traction as regulators lag behind
    • After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023
    • Excitement associated with FDA approval of Rinvoq in Crohn’s disease
  • Sectors

    Sections

    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area

    Latest

    • Touchlight boosts DNA manufacturing capacity with latest expansion
    • After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023
    • Daiichi Sankyo receives Japan’s MHLW approval for VANFLYTA
  • Themes

    Sections

    • Artificial Intelligence
    • Cloud
    • Corporate Governance
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19

    Latest

    • ICR and Royal Marsden NHS Foundation Trust open new integrated pathology unit
    • Sanofi deploys Veeva Systems’ solutions to improve quality management
    • Recursion plans $87.5m acquisitions to shore up AI drug discovery
  • Insights

    Sections

    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media

    Latest

    • Who’s innovating where? Environmental sustainability related patent filings activity decreased by 23% in the pharmaceutical industry in Q1 2023
    • Who’s hiring who? Social Responsibility hiring activity decreased by 38% in the pharmaceutical industry in Q1 2023
    • Takeda reports 12.8% rise in FY2022 revenue
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content

    Latest

    • Medicines adherence: Overcoming pharma’s biggest barrier to treatment success
    • Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 
    • Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 
  • Events
  • Reports
  • Premium Insights
PT
February 22, 2022

4th Neuroimmunology Drug Development Summit

By IndiaProduction

IndiaProduction

Share this article

Recommended Reports

  • ReportsLogo
    Reports

    C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) Drugs in Development by Therapy Areas and I...

    GlobalData
  • ReportsLogo
    Reports

    Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC ...

    GlobalData
View all

IndiaProduction

PharmaceuticalTechnology

The leading site for news and procurement in the pharmaceutical industry

  • About us
  • Advertise with us
  • License our content
  • Contact us
  • Editorial approach
  • Newsletters
  • Our marketing solutions
  • Privacy policy
  • Terms and conditions

Powered by Pharma Tech Logo

© Verdict Media Limited 2023

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.